Australia markets closed

PGNY Feb 2022 35.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
21.97+1.71 (+8.44%)
As of 3:38PM EDT. Market open.
Full screen
Previous close20.26
Open21.97
Bid21.10
Ask23.00
Strike35.00
Expiry date2022-02-18
Day's range21.97 - 21.97
Contract rangeN/A
Volume1
Open interest25
  • Motley Fool

    3 Innovative Growth Stocks That'll Make You Richer Through 2025

    When you're investing in growth stocks, especially in the healthcare space, you might be willing to accept a company's unprofitability for a period of time, provided its revenue is increasing. All three companies I'm about to discuss are profitably making products that are substantially better than the mainstream standards in their fields. For complex and serious wounds, however, they might be better served by one of the advanced wound care products made by Organogenesis Holdings (NASDAQ: ORGO).

  • Simply Wall St.

    Progyny (NASDAQ:PGNY) shareholder returns have been solid, earning 122% in 1 year

    Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...

  • GlobeNewswire

    Progyny, Inc. to Present at the BofA Global Healthcare Conference

    NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021 at 10:55 A.M. Eastern Time, or 3:55 P.M. British Summer Time. A live au